pazopanib has been researched along with Esthesioneuroblastoma--Olfactory* in 1 studies
1 other study(ies) available for pazopanib and Esthesioneuroblastoma--Olfactory
Article | Year |
---|---|
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.
Topics: Aged; Esthesioneuroblastoma, Olfactory; Female; Fumarate Hydratase; Humans; Indazoles; Mutation; Nasal Cavity; Neoplasm Recurrence, Local; Nose Neoplasms; Pyrimidines; Remission Induction; Retreatment; Sulfonamides; Time Factors | 2021 |